NIH unit awards $36M grant to Beth Israel for AIDS vaccine research

07/25/2011 | American City Business Journals

The NIH's National Institute of Allergy and Infectious Diseases has awarded a $36 million grant to Beth Israel Deaconess Medical Center to spearhead a consortium that aims to study AIDS vaccines in nonhuman primates. The grant will be distributed over five years. "The goal of the consortium is to elucidate the earliest immunologic and pathologic events at mucosal surfaces following virus infection, and to determine the ability of multiple leading vaccine candidates to block or to attenuate these events," said Dr. Dan Barouch, chief of vaccine research at Beth Israel.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC